Cognitive changes in older adults receiving pharmacotherapy for treatment-resistant depression: a secondary analysis of the OPTIMUM randomised controlled trial
Authors
Jordan F. Karp (ORCID: https://orcid.org/0000-0002-5171-5028)
J. Philip Miller (ORCID: https://orcid.org/0000-0003-4568-6846)
Nicholas J. Ainsworth (ORCID: https://orcid.org/0000-0002-6340-2336)
Benoit H. Mulsant (ORCID: https://orcid.org/0000-0002-0303-6450)
Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Cognitive changes in older adults receiving pharmacotherapy for treatment-resistant depression: a secondary analysis of the OPTIMUM randomised controlled trial
Jordan F. Karp, J. Philip Miller, Nicholas J. Ainsworth, Benoit H. Mulsant et al.
Citations
1 citations
Journal
The Lancet Healthy Longevity
Topics
Treatment of Major Depression
Field-Weighted Citation Impact (FWCI)
1.39
article
Cognitive changes in older adults receiving pharmacotherapy for treatment-resistant depression: a secondary analysis of the OPTIMUM randomised controlled trial
Jordan F. Karp, J. Philip Miller, Nicholas J. Ainsworth, Benoit H. Mulsant, Meryl A. Butters, Hanadi Ajam Oughli, Eric J. Lenze, Marie Anne Gebara, Torie R Gettinger, Charles F. Reynolds, Emily Lenard, Helen Lavretsky, Michael Yingling, Ginger E. Nicol, Patrick J. Brown
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Healthy LongevityVol. 6(10)
Institutions
Centre for Addiction and Mental Health (CA), University of Arizona (US), University of California, Los Angeles (US), University of Pittsburgh (US), Washington University in St. Louis (US), Neurobehavioral Systems (US), Columbia University (US)
Funders
U.S. Department of Defense, Biogen, Patient-Centered Outcomes Research Institute, Johns Hopkins University, University of Pittsburgh, Fondation Brain Canada, Providence Health Care, Centre for Addiction and Mental Health Foundation, Usona Institute, Michael Smith Health Research BC, University of Oxford, University of Toronto, National Institutes of Health, McDonnell Center for Systems Neuroscience, University of Maryland School of Public Health, Canadian Institutes of Health Research, National Institute of Mental Health, Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis